Interestingly, treatment of rat hearts with isoproterenol, a classical model of cardiac hypertrophy, increased phosphatase activity (PP1 and PP2A), whereas coadministration of the β-adrenoceptor blocker propranolol not only inhibited cardiac hypertrophy but also normalized the activity of phosphatases [26]. Here, PTPA is linked to cardiac hypertrophy.